<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 20-year-old woman required urgent replacement of a calcified prosthetic mitral porcine xenograft with a mechanical one during the 32nd week of pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Five weeks later the patient delivered a <z:mpath ids='MPATH_458'>normal</z:mpath> child </plain></SENT>
<SENT sid="2" pm="."><plain>Following delivery the patient refused oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment and 7 months later she underwent emergency removal of a prosthetic valve <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Six months later, still refusing <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment, she died of cerebral embolization </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that the replacement of a degenerated biologic valve with another biologic valve should be considered in patients who refuse <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment and that patients with prosthetic xenografts should be kept under close medical follow-up, including echocardiography because of possible accelerated xenograft failure during and/or following pregnancy </plain></SENT>
</text></document>